Spots Global Cancer Trial Database for A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
Official Title: An Observational Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Second- or Later-Line Therapy in Chinese Patients With HER2 Positive Advanced Breast Cancer
Study ID: NCT05945927
Conditions
Interventions
Study Description
Brief Summary: This study is a post-marketing, observational, multicenter, prospective study. It will investigate the the safety and effectiveness of T-DM1 in the Chinese population in real-world clinical practice.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Anyang Tumor Hosptial, Anyang City, , China
Affiliated Hospital of Hebei University, Baoding, , China
Cancer Hospital Chinese Academy of Medical Sciences., Beijing, , China
Beijing Hospital; Internal Medicine-Oncology, Beijing, , China
the First Hospital of Jilin University, Changchun, , China
West China Hospital of Sichuan University, Chengdu City, , China
Fujian Cancer Hospital, Fuzhou, , China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University; Breast Tumor Center, Guangzhou City, , China
Sun yat-sen University Cancer Center; Internal Medicine of Oncology, Guangzhou, , China
The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, , China
Harbin Medical University Cancer Hospital, Harbin, , China
Anhui Province Cancer Hospital, Hefei City, , China
Jiangmen Central Hospital, Jiangmen, , China
The First Affiliated Hospital Of Shandong First Medical University, Jinan City, , China
Qilu Hospital of Shandong University, Jinan, , China
Dongyang People's Hospital, Jinhua, , China
The Third Hospital of Nanchang, Nanchang City, , China
Nanjing Gulou Hospital, Nanjing, , China
Guangxi Cancer Hospital of Guangxi Medical University, Nanning City, , China
Affiliated Hospital of Nantong University, Nantong, , China
Ningbo No.2 Hospital, Ningbo, , China
China Medical University (CMU) First Affiliated Hospital, Shenyang City, , China
Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center, Shenzhen City, , China
Shanxi Provincial Cancer Hospital, Taiyuan, , China
Tianjin Cancer Hospital; Department of Breast Oncology, Tianjin, , China
Cancer Hospital Affliated to Xinjiang Medical University, Urumqi City, , China
Weifang People's Hospital, Weifang City, , China
Union Hospital of Tongji Medical College, Dept. of Cancer Center; Cancer Center, Wuhan, , China
Hubei Cancer Hospital, Wuhan, , China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, , China
Yibin Second People's Hospital, Yibin, , China
Zhejiang Cancer Hospital, Zhejiang, , China
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
